Opioid Induced Hyperalgesia: possible to avoid by gradual reduction compared to acute withdrawal from remifentanil?

Trial Profile

Opioid Induced Hyperalgesia: possible to avoid by gradual reduction compared to acute withdrawal from remifentanil?

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Oct 2014

At a glance

  • Drugs Remifentanil (Primary)
  • Indications Hyperalgesia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 05 Oct 2012 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01702389)
    • 20 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top